Oral treosulfan as second-line treatment in platinum-resistant ovarian cancer: a phase II study. The Danish Ovarian Cancer Study Group (Q50561845)
scientific article published in May 1998
Language:
(P31) (Q13442814)
(P304) 100-102
(P407) (Q1860)
(P433) 2
(P478) 69
(P577) Friday, May 1, 1998
(P921) (Q172341)
(P1433) (Q5625182)
(P1476) "Oral treosulfan as second-line treatment in platinum-resistant ovarian cancer: a phase II study. The Danish Ovarian Cancer Study Group" (language: en)
(P2093) Keldsen N
Madsen EL
Havsteen H
Kamby C
Laursen L
Sandberg E
other details
description scientific article published in May 1998

External Links